P. Poortmans

发表

Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

R. Huddart, C. Faivre-Finn, C. Coles, 2018, British Journal of Cancer.

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Laurence Collette, Rodrigo Arriagada, Erik Van Limbergen, 2015, The New England journal of medicine.

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Laurence Collette, Jos J. Jager, Harry Bartelink, 2007 .

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.

Mechthild Krause, Meritxell Arenas, Marianne C Aznar, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

327 oral A RELIABLE AND FAST (REAL-TIME) POSITIONING SYSTEM (NAVOTEK(r)) REDUCES THE OVERALL TIME PER TREATMENT SESSION.

F. V. Heuvel, K. Haustermans, B. Corn, 2011 .

Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets

Andre Dekker, Uwe Just, Mechthild Krause, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.

Michel Bolla, Akos Gulyban, Laurence Collette, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for primary radiotherapy of patients with prostate cancer.

Michel Bolla, Raymond Miralbell, Alberto Bossi, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.

Michel Bolla, Raymond Miralbell, Zvi Symon, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting.

Damien C Weber, Akos Gulyban, A. Fairchild, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility.

Damien C Weber, Vincent Gregoire, Akos Gulyban, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A population-based study of radiotherapy in a cohort of patients with rectal cancer diagnosed between 1996 and 2000.

J. Coebergh, H. Rutten, P. Poortmans, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A population based study of radiotherapy in a cohort of patients with breast cancer diagnosed between 1996 and 2000.

J. Coebergh, H. Rutten, P. Poortmans, 2007, European journal of cancer.

Quality indicators for breast cancer: revisiting historical evidence in the context of technology changes.

H. Bartelink, M. Aznar, P. Poortmans, 2012, Seminars in radiation oncology.

The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts.

J. Horiot, M. Piérart, V. Kouloulias, 2003, European journal of cancer.

Postoperative Radiation Therapy after Nipple‐Sparing or Skin‐Sparing Mastectomy: A Survey of European, North American, and South American Practices

T. Buchholz, P. Poortmans, G. Marta, 2017, The breast journal.

Three-Dimensional Treatment Planning and Conformal Therapy

J. Purdy, C. Perez, P. Poortmans, 2011 .

Cardiovascular surveillance in breast cancer treatment: A more individualized approach is needed.

A. Maas, T. Leiner, F. Atsma, 2016, Maturitas.

Quality Management and Safety in Radiation Oncology

J. Purdy, E. Klein, C. Hurkmans, 2011 .

Why observational studies are important in comparative effectiveness research: the effect of breast-conserving therapy and mastectomy in the real world

S. Siesling, L. Strobbe, P. Poortmans, 2016 .

Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials.

H. Bartelink, P. Evans, J. Yarnold, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030.

D. Verellen, Y. Lievens, U. Ricardi, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Postoperative radiation therapy for rectal cancer: an interim analysis of a prospective, randomized multicenter trial in The Netherlands.

H. Hamers, P. Coucke, W. van Putten, 1992, Cancer.

Radiation of the Internal Mammary Nodes: Is There a Benefit?

T. Whelan, B. Haffty, P. Poortmans, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluation.

Karin Haustermans, Raymond Oyen, Jan Verstraete, 2013, International journal of radiation oncology, biology, physics.

Evidence based radiation oncology: breast cancer.

P. Poortmans, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A bright future for radiotherapy in breast cancer.

P. Poortmans, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance in radiotherapy: from radiation physics to patient- and trial-oriented control procedures.

J. Bernier, P. Poortmans, J. Horiot, 2002, European journal of cancer.

Acute toxicity and surgical complications after preoperative (chemo)radiation therapy for rectal cancer in patients with inflammatory bowel disease.

I. Nagtegaal, C. Marijnen, P. Poortmans, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925

H. Bartelink, V. Budach, P. Maingon, 2014 .

Physics of Radiotherapy Planning and Delivery

J. Purdy, C. Perez, S. Levitt, 2011 .

Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT--Results of the randomized EORTC Phase III trial 22961

M. Piérart, L. Collette, M. Bolla, 2007 .

Two sides of the spectrum: Improving local control in young patients and decreasing treatment burden in low risk patients

P. Poortmans, 2014 .

The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment.

H. Bartelink, J. Horiot, L. Boersma, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands : a population-based study

S. Linn, S. Siesling, L. Strobbe, 2016 .

Radiotherapy for elderly patients with low-risk breast cancer.

A. Kuten, O. Kaidar-Person, P. Poortmans, 2015, The Lancet. Oncology.

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

M. van Glabbeke, M. J. van den Bent, M. Taphoorn, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trend and Variation in Treatment of Localized Prostate Cancer in the Southern Part ofThe Netherlands, 1988–1996

J. Coebergh, A. Hendrikx, P. Post, 1999, European Urology.

Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group.

P. Maingon, A. Monti, C. Hurkmans, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925.

H. Bartelink, M. Guckenberger, F. van der Leij, 2021, Journal of the National Cancer Institute.

Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

E. van Limbergen, H. Bartelink, J. Horiot, 2017, JAMA oncology.

Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study

P. Bult, N. Simone, P. Navarria, 2017, Breast Cancer Research and Treatment.

OC-0523: Lymph node RT improves survival in breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925.

H. Bartelink, V. Budach, P. Maingon, 2014 .

Locoregional Treatment in Early Stage Breast Cancer: More Evidence and Yet More Questions?

T. Whelan, P. Poortmans, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Treatment of Regional Lymph Nodes in Breast Cancer-Evidence in Favor of Radiation Therapy.

C. Coles, J. Bernier, P. Poortmans, 2016, JAMA oncology.

Elective Nodal Irradiation in Breast Cancer: Time for Trials on the Basis of Tumor Biology.

L. Livi, O. Kaidar-Person, P. Poortmans, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate

P. Poortmans, 2014, The Lancet.

Post-lumpectomy radiation therapy boost in breast cancer patients: evidence revisited

F. Geara, P. Poortmans, Y. Zeidan, 2021, Ecancermedicalscience.

Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.

H. Putter, H. Bartelink, E. Noordijk, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years

V. Tjan-Heijnen, G. Nieuwenhuijzen, M. Ernst, 2011, Breast Cancer Research and Treatment.

IN REPLY: Morgan and Robertson underline our remarkable

H. Bartelink, J. Horiot, L. Collette, 2007 .

Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all.

N. E. El Saghir, A. Tfayli, P. Poortmans, 2020, Critical reviews in oncology/hematology.

Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: a review.

J. Bernier, P. Poortmans, 2015, Breast.

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

I. Barillot, H. Bartelink, J. Horiot, 2001, The New England journal of medicine.

Clinical and technological transition in breast cancer.

H. Marsiglia, P. Poortmans, M. Algara, 2013, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.

M. Amichetti, U. Abacıoğlu, RobertI Miller, 2006, The Lancet. Oncology.

Using loco-regional recurrence as an indicator of the quality of breast cancer treatment.

J. Coebergh, M. Ernst, P. Poortmans, 2004, European journal of cancer.

Tilburg University Perceived information provision and satisfaction among lymphoma and multiple myeloma survivors-results from a Dutch population-based study

F. Mols, O. Husson, P. Poortmans, 2012 .

ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer

W. Dries, H. Rutten, F. Calvo, 2020, Clinical and translational radiation oncology.

ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer

W. Dries, H. Rutten, F. Calvo, 2020, Clinical and translational radiation oncology.

Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder

M. Piérart, L. Collette, M. Bolla, 2008, Acta oncologica.

Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation.

H. Bartelink, J. Horiot, M. Piérart, 1999, Acta oncologica.

Breast Cancer: Intact and Post Mastectomy

T. Buchholz, M. Aznar, P. Poortmans, 2011 .

Impact of a boost dose of 16 GY on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost’ trial

J. Peterse, H. Bartelink, J. Horiot, 2000 .

Radiation Therapy for Hodgkin Lymphoma and Other Hematopoietic Disorders

P. Poortmans, C. Lee, 2011 .

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

J. Raemaekers, A. Hagenbeek, G. Salles, 2007, The New England journal of medicine.

Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin's lymphoma.

J. Raemaekers, P. Poortmans, E. Raaijmakers, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.

E. Noordijk, L. Specht, Y. Lievens, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

J. Armitage, E. Thiel, F. Cavalli, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality Assurance for Multi-Institutional Clinical Trials

J. Purdy, P. Poortmans, 2011 .

Postoperative radiation therapy for rectal cancer: an interim analysis of a prospective, randomized multicenter trial in The Netherlands.

H. Hamers, P. Poortmans, 1992, Cancer.

Hospital variation in referral for primary radiotherapy in South Netherlands, 1988-1999.

J. Coebergh, P. Poortmans, J. C. Vulto, 2005, European journal of cancer.

The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy.

A. Voogd, P. Poortmans, M. Essers, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Postmastectomy radiotherapy should be the standard of care for all women with involved axillary nodes

J. Overgaard, M. Overgaard, P. Poortmans, 2007 .

The impact of socioeconomic status on prostate cancer treatment and survival in the southern Netherlands.

J. Coebergh, M. Louwman, P. Poortmans, 2013, Urology.

The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge

J. Cuzick, Ruth Etzioni, R. Jagsi, 2022, The Lancet.

Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.

H. Bartelink, L. Boersma, E. van Werkhoven, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes of postoperative radiation therapy for breast cancer in older women according to age and comorbidity status: An observational retrospective study in 752 patients.

A. Fourquet, M. Carton, P. Poortmans, 2018, Journal of geriatric oncology.

ESTRO consensus guidelines ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer

L. Boersma, J. Yarnold, V. Remouchamps, 2015 .

E4. Current clinical issues in breast cancer

S. Darby, L. Boersma, I. Kunkler, 2010 .

Quality Assurance in the EORTC Randomized Trial 22922/10925 Investigating the Role of Irradiation of the Internal Mammary and Medial Supraclavicular Lymph Node Chain Works

P. Lambin, L. Collette, G. Tienhoven, 2006, Strahlentherapie und Onkologie.

International study on low‐grade primary central nervous system lymphoma

J. Blay, E. Thiel, H. Stein, 2006, Annals of neurology.

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

J. Witjes, G. Groenewegen, F. V. van Leeuwen, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.

J. Blay, E. Thiel, J. Connors, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

H. Bartelink, M. Piérart, L. Collette, 2010, Acta oncologica.

Establishing a Global Radiation Oncology Collaboration in Education (GRaCE): Objectives and priorities.

R. Pötter, M. Giuliani, K. Benstead, 2015, Radiotherapy and Oncology.

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.

H. Bartelink, J. Horiot, J. Jager, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Interobserver Study of Prostatic Fossa Clinical Target Volume Delineation in Clinical Practice: Are Regions of Recurrence Adequately Targeted?

B. Corn, M. Wygoda, Z. Symon, 2010, American journal of clinical oncology.

When Can We Avoid Postmastectomy Radiation Following Primary Systemic Therapy?

P. Poortmans, Á. Montero, R. Ciérvide, 2019, Current Oncology Reports.

Abstract GS4-02: Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials

T. Whelan, T. Kühn, R. Gray, 2019, General Session Abstracts.

Targeted Intraoperative Radiotherapy for Early Breast Cancer.

M. Leonardi, P. Poortmans, G. Fastner, 2020, JAMA oncology.

ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer.

F. Sedlmayer, M. Leonardi, F. Calvo, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerated partial breast irradiation: more questions than answers?

C. Coles, J. Bliss, P. Poortmans, 2019, The Lancet.

Effect of COVID-19 pandemic on practice in European radiation oncology centers☆

Y. Lievens, U. Ricardi, P. Poortmans, 2020, Radiotherapy and Oncology.

Cancer and COVID-19: what do we really know?

P. Poortmans, V. Guarneri, M. Cardoso, 2020, The Lancet.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Mike Clarke, Yasuo Ohashi, Michael Gnant, 2018, The Lancet. Oncology.

Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspective.

V. Valentini, Y. Lievens, P. Poortmans, 2015, The Lancet. Oncology.

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

R. Abdah-bortnyak, A. Kuten, U. Abacıoğlu, 2008, Gynecologic oncology.

Primary central nervous system lymphoma

P. Poortmans, 2009 .

Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high‐dose methotrexate, and R‐DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study

M. Kersten, J. Baars, P. Lugtenburg, 2017, Hematological oncology.

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer

L. Rigter, F. V. van Leeuwen, O. Visser, 2018, Cancer medicine.

“ Simplicity is complexity resolved ”: the case of postoperative radiation therapy after breast conservation

P. Franco, U. Ricardi, P. Poortmans, 2016 .

Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.

H. Bartelink, L. Boersma, E. van Werkhoven, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

OP-JNCI210114 1360..1368

H. Bartelink, V. Budach, M. Guckenberger, 2021 .

In response to Haas RL et al.

F. Calvo, P. Poortmans, J. M. Asencio, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

General practitioners and referral for palliative radiotherapy: a population-based survey.

M. Louwman, P. Poortmans, J. Coebergh, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.

Mechthild Krause, Meritxell Arenas, Marianne C Aznar, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Target Volume Coverage and Organ at Risk Doses for Left-sided Whole-breast Irradiation With or Without Internal Mammary Chain Irradiation: A Comparison Between Three Techniques Representing the Past and the Present.

M. Hoogeman, A. Petoukhova, H. Struikmans, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation.

L. Boersma, I. Mjaaland, M. Nielsen, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

OC-0568: Accelerated PBI VS standard radiotherapy (IRMA trial): interim cosmetic and toxicity results

F. Lohr, G. Frezza, S. Kaleci, 2017 .

Ten-Year Survival Results of a Randomized Trial of Irradiation of Internal Mammary Nodes After Mastectomy

P. Poortmans, 2014 .

Significance of margins of excision on breast cancer recurrence (on behalf of the EORTC Radiotherapy, Breast Cancer Groups)

H. Bartelink, J. Horiot, J. Jager, 2004 .

Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials?

L. Collette, A. Fairchild, C. Hurkmans, 2012, European journal of cancer.

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.

E. van Limbergen, H. Bartelink, J. Horiot, 2015, The Lancet. Oncology.

The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years.

L. V. van de Poll-Franse, G. Nieuwenhuijzen, G. Creemers, 2007, Cancer.

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis

M. J. van den Bent, M. Taphoorn, M. Schuurmans, 2010, British journal of haematology.

Regarding Current Recommendations for Postmastectomy Radiation Therapy in Patients With One to Three Positive Axillary Lymph Nodes.

L. Marks, O. Kaidar-Person, P. Poortmans, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose MTX-based chemotherapy followed by consolidating radiotherapy in Non-Aids related Primary Central Nervous System Lymphoma.

J. Raemaekers, M. Taphoorn, M. Glabbeke, 2002 .

Duration of androgen suppression in the treatment of prostate cancer.

M. Piérart, L. Collette, T. D. de Reijke, 2009, The New England journal of medicine.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique

H. Bartelink, P. Evans, J. Yarnold, 2014 .

Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.

J. Curschmann, M. Bolla, R. Tsang, 2006, International journal of radiation oncology, biology, physics.

Clinical implementation of 3D printing in the construction of patient specific bolus for electron beam radiotherapy for non-melanoma skin cancer.

Martijn Kusters, M. Wendling, R. Canters, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network.

R. Miralbell, J. Kaanders, D. Aebersold, 2011, International journal of radiation oncology, biology, physics.

Breast cancer

C. Denkert, M. Morrow, S. Loibl, 2021, The Lancet.

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

S. Linn, S. Siesling, L. Strobbe, 2016, The Lancet. Oncology.

Satisfaction with information provision is associated with baseline but not with follow-up quality of life among lymphoma patients: Results from the PROFILES registry

L. V. van de Poll-Franse, F. Mols, S. Oerlemans, 2014, Acta oncologica.

Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study.

A. Taghian, L. Boersma, RobertI Miller, 2012, International journal of radiation oncology, biology, physics.

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Bingshu E. Chen, D. Berry, P. Fasching, 2019, The Lancet.

Local Treatment of Triple-Negative Breast Cancer

I. Rubio, O. Kaidar-Person, P. Poortmans, 2021, Cancer journal.

De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or not to Boost?

M. Piccart, F. Geara, E. de Azambuja, 2020, International journal of radiation oncology, biology, physics.

Post-Mastectomy Radiation Therapy in HER-2 Positive Breast Cancer Patients: Analysis of the HERA Trial.

M. Piccart, F. Geara, E. de Azambuja, 2020, International journal of radiation oncology, biology, physics.

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

Michel Bolla, Laurence Collette, John Kurtz, 2008, European journal of cancer.

ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer.

R. Krempien, F. Calvo, P. Poortmans, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intraoperative radiation therapy (IORT) for soft tissue sarcoma - ESTRO IORT Task Force / ACROP recommendations.

F. Calvo, P. Poortmans, F. Roeder, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.

M. Amichetti, M. Ozsahin, S. Sundar, 2015, International journal of radiation oncology, biology, physics.

Prostatic Duct Adenocarcinoma: Clinical Characteristics, Treatment Options, and Outcomes – a Rare Cancer Network Study

A. Zietman, J. Efstathiou, RobertI Miller, 2010, Oncology Research and Treatment.

Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network.

N. Magné, M. Bolla, M. Ozsahin, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991.

L Collette, O Matzinger, M Bolla, 2009, European journal of cancer.

Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes.

H. Bartelink, M. Piérart, L. Collette, 2007, European journal of cancer.

ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer

R. Krempien, F. Calvo, P. Poortmans, 2020, Clinical and translational radiation oncology.

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

J. Raemaekers, M. Louwman, F. V. van Leeuwen, 2015, The New England journal of medicine.

Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands.

D. Huitema, L. van Zuylen, F. Amant, 2022, European journal of cancer.

A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients.

M. J. van de Vijver, H. Bartelink, L. Boersma, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?

L Collette, A Fourquet, W Van den Bogaert, 2003, European journal of cancer.

Cognitive status and quality of life after treatment for primary CNS lymphoma

J. Menten, M. J. van den Bent, H. Kluin-Nelemans, 2004, Neurology.

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

E. Noordijk, L. Specht, Y. Lievens, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients.

C. Denkert, S. Loibl, G. von Minckwitz, 2015, JAMA oncology.

Radiotherapy preserves fingers in the management of subungual squamous cell carcinoma, obviating the need for amputation.

R. Haas, P. Poortmans, D. Grootenboers, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

4th symposium on primary breast cancer in older women. Theme: putting personalized care into practice (Held: 3 March 2017)

Heather M. Stone, K. Cheung, E. Brain, 2017 .

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.

L Collette, A Fourquet, E Van Limbergen, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.

J C Horiot, L Collette, E Van Limbergen, 1999, International journal of radiation oncology, biology, physics.

Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study

P. Westenend, S. Siesling, L. Strobbe, 2018, International journal of cancer.

Radiation oncology enters the era of individualised medicine.

P. Span, O. Kaidar-Person, P. Poortmans, 2017, The Lancet. Oncology.

Regional Nodal Irradiation in Early-Stage Breast Cancer.

H. Struikmans, H. Bartelink, H. Struikmans, 2015, The New England journal of medicine.

Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.

RobertI Miller, M. Ozsahin, N. Beşe, 2012, International journal of radiation oncology, biology, physics.

Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study.

R. Mirimanoff, A. Sun, RobertI Miller, 2006, International journal of radiation oncology, biology, physics.

Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.

V. Tjan-Heijnen, V. Tjan-Heijnen, G. Nieuwenhuijzen, 2013, European journal of cancer.

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.

E. van Limbergen, H. Bartelink, V. Budach, 2020, The Lancet. Oncology.

Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery.

S. O'toole, C. McNeil, J. Beith, 2019, Critical reviews in oncology/hematology.

Always on a Friday: referral pattern for metastatic spinal cord compression.

P. Poortmans, B. Cloin, E. Koiter, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Always on a Friday? Time pattern of referral for spinal cord compression.

P. Poortmans, E. Raaijmakers, A. Vulto, 2001, Acta oncologica.

Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study

M. Bolla, R. Tsang, B. Castelain, 2006, BMC Cancer.

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

M. Kersten, A. Hagenbeek, G. Salles, 2009, The Lancet. Oncology.

A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer.

Hannah M. Dahn, R. Jagsi, A. Nichol, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network.

R. Mirimanoff, J. Bernier, A. Allal, 2003, International journal of radiation oncology, biology, physics.

Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study

R. Mirimanoff, A. Taghian, P. Scalliet, 2008, BMC Cancer.

Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.

I. Barillot, H. Bartelink, J. Horiot, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.

S. Marnitz, R. Mirimanoff, R. Miralbell, 2003, International Journal of Radiation Oncology, Biology, Physics.

Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study.

R. Mirimanoff, J. Thariat, M. Ozsahin, 2010, International journal of radiation oncology, biology, physics.

Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study.

D. Pasquier, O. Micke, S. Villà, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.

L. Collette, M. Bolla, J. Bosset, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients

L. Koppert, S. Siesling, M. Tilanus-Linthorst, 2018, International journal of cancer.

The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study.

R. Miralbell, G. Soete, G. Studer, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Conducting radiogenomic research--do not forget careful consideration of the clinical data.

Johannes A Langendijk, Clare Griffin, Dirk De Ruysscher, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.

R. Müller, H. Bartelink, J. Horiot, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.

H. Bartelink, J. Horiot, J. Jager, 1999, International journal of radiation oncology, biology, physics.

Perceived information provision and satisfaction among lymphoma and multiple myeloma survivors—results from a Dutch population-based study

L. V. van de Poll-Franse, F. Mols, S. Oerlemans, 2012, Annals of Hematology.

Patterns and predictors of first and subsequent recurrence in women with early breast cancer

S. Siesling, L. Strobbe, R. Bretveld, 2017, Breast Cancer Research and Treatment.

The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future.

J. Bernier, P. Poortmans, J. B. Davis, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands.

J. Coebergh, V. Tjan-Heijnen, M. Janssen-Heijnen, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years.

S. Siesling, L. Strobbe, M. Smidt, 2018, European journal of cancer.

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival

C. Groothuis-Oudshoorn, S. Siesling, L. Strobbe, 2017, British Journal of Cancer.

Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosis

J. Coebergh, M. Janssen-Heijnen, O. Husson, 2014, BJU international.

Use of primary radiotherapy for rectal cancer in the Netherlands between 1997 and 2008: a population-based study.

J. Coebergh, C. Koning, S. Siesling, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer from 1997 till 2008: a population-based study in the Netherlands.

C. Koning, L. Veerbeek, J. Immerzeel, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008.

J. Coebergh, C. Koning, H. Struikmans, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Elective radiotherapy of the regional lymph node areas in breast cancer].

P. Poortmans, 2006, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Nationwide population‐based study of trends and regional variation in breast‐conserving treatment for breast cancer

L. Koppert, S. Siesling, L. Strobbe, 2018, The British journal of surgery.

Infiltrating lobular breast cancer: truly a separate entity! Consequences for radiation therapy.

E. van Limbergen, M. Bollet, P. Poortmans, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The effect of honey compared to conventional treatment on healing of radiotherapy-induced skin toxicity in breast cancer patients

P. Poortmans, M. Moolenaar, Robert Louwrens Poorter, 2006, Acta oncologica.

Defining a Leader Role curriculum for radiation oncology: A global Delphi consensus study.

M. Giuliani, K. Benstead, J. Eriksen, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper.

M. Piccart, D. Lacombe, D. Kelly, 2017, European journal of cancer.

Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population‐based study

V. Lemmens, H. Rutten, J. Pruijt, 2013, Diabetic medicine : a journal of the British Diabetic Association.

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience

A. Fourquet, P. Poortmans, Y. Kirova, 2018, Oncotarget.

Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation.

P. Poortmans, M. Essers, S. Hol, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.

V. Tjan-Heijnen, P. Poortmans, A. Voogd, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger.

P. Huibers, L. V. van de Poll-Franse, M. Ernst, 2010, Breast.

The safety of breast‐conserving therapy in patients with breast cancer aged ≤40 years

L. V. van de Poll-Franse, G. Nieuwenhuijzen, G. Creemers, 2007 .

The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.

H. Bartelink, J. Horiot, J. Jager, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.

D. Huyskens, B. Mijnheer, W. F. Van den Bogaert, 2003, European journal of cancer.

Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008.

J. Coebergh, C. Koning, M. Janssen-Heijnen, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.

H. Bartelink, J. Horiot, M. Piérart, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer.

W. F. Van den Bogaert, Y. Lievens, P. Poortmans, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.

D. Rietveld, E. Rutgers, J. Theuws, 2016, International journal of radiation oncology, biology, physics.

Surgery and radiation therapy of triple-negative breast cancers: From biology to clinics.

J. Bernier, P. Poortmans, 2016, Breast.

Platinum exposure and cause‐specific mortality among patients with testicular cancer

J. Witjes, G. Groenewegen, F. V. van Leeuwen, 2019, Cancer.

Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines.

Tomas Janssen, L. Boersma, J. Duppen, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation.

Tomas M Janssen, Corine van Vliet-Vroegindeweij, L. Boersma, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Optimal approach in early breast cancer: Radiation therapy

P. Poortmans, 2013, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

PO-0625 EXTERNAL BEAM PARTIAL BREAST IRRADIATION: DIFFERENCE IN PRE-AND POSTOPERATIVE TARGET VOLUME DELINEATION

L. Boersma, P. Elkhuizen, T. Janssen, 2012 .

Development of Staffing, Workload and Infrastructure in Member Departments of the European Organisation for Research and Treatment of Cancer (EORTC) Radiation Oncology Group.

A. Monti, N. Andratschke, C. Hurkmans, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Field flatness and symmetry of photon beams: review of the current recommendations.

C. Kappas, P. Sandilos, P. Poortmans, 2003, Technology and health care : official journal of the European Society for Engineering and Medicine.

Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial.

H. Bartelink, L. Collette, E. van Werkhoven, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of the boost dose on local control and survival in patients with early stage breast cancer after a microscopically incomplete lumpectomy : 10 years results of the randomised EORTC boost trial 22881/10882.

H. Bartelink, J. Horiot, M. Piérart, 2006 .

Radiotherapy in DCIS, an underestimated benefit?

Jacques Bernier, J. Bernier, P. Poortmans, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

T-Staging and Target Volume Definition by Imaging in Breast Tumours

P. Poortmans, Roberto C. Delgado Bolton, A. C. Terán, 2020 .

Benchmarking Radiation TherapisT (RTT) education for safe practice: The time is now.

M. Leech, M. Coffey, P. Poortmans, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03).

L. Boersma, S. Linn, J. Wesseling, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluating the Age‐Based Recommendations for Long‐Term Follow‐Up in Breast Cancer

L. Boersma, S. Siesling, I. Vliegen, 2020, The oncologist.

Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.

A. Hart, J. Peterse, H. Bartelink, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.

E. van Limbergen, H. Bartelink, J. Horiot, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerated partial breast irradiation (APBI): Are breath-hold and volumetric radiation therapy techniques useful?

P. Poortmans, M. Essers, S. Hol, 2014, Acta oncologica.

An actualised population‐based study on the use of radiotherapy in breast cancer patients in the Netherlands

S. Siesling, H. Struikmans, P. Poortmans, 2019, The breast journal.

Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

R. Huddart, C. Faivre-Finn, C. Coles, 2018, British Journal of Cancer.

Breast-conserving therapy versus mastectomy

S. Siesling, P. Poortmans, M. V. van Maaren, 2016, Oncoscience.

European Society for Therapeutic Radiology and Oncology (ESTRO) teaching course and workshop E6. Recent advances in breast cancer radiotherapy

A. Fourquet, W. Budach, P. Poortmans, 2008 .

The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).

J. Lagendijk, J. Lagendijk, D. Huyskens, 2001, International journal of radiation oncology, biology, physics.

OC-0522: 3D-CRT/IMRT with/without short term androgen deprivation in localized T1b-cT2aN0M0 prostate cancer (EORTC 22991)

L. Collette, M. Bolla, A.C.M. van den Bergh, 2014 .

Contributions and Risks of Radiation Therapy in Managing Cancer During Pregnancy

J. Venselaar, H. Struikmans, P. Poortmans, 2016 .

Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients

B. Offersen, P. Poortmans, 2014 .

Detection of local recurrence following breast-conserving treatment in young women with early breast cancer: optimization of long-term follow-up strategies.

G. Nieuwenhuijzen, A. Voogd, P. Poortmans, 2013, Breast.

E3. What is Hot in breast cancer radiation oncology in 2012

R. Orecchia, P. Poortmans, 2012 .

Should breathing adapted radiotherapy also be applied for right-sided breast irradiation?

D. Cobben, P. Poortmans, M. Essers, 2016, Acta oncologica.

Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).

J. Raemaekers, E. Noordijk, Y. Lievens, 2005, International journal of radiation oncology, biology, physics.

The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial

H. Bartelink, J. Jager, L. Collette, 2008 .

Cause-specific mortality among patients with Hodgkin lymphoma (HL) up to 40 years after treatment.

J. Raemaekers, M. Louwman, J. Zijlstra, 2014 .

6N Irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer: state of the day of EORTC phase III trial 22922/10925 with 4004 patients

H. Bartelink, L. Collette, V. Budach, 2010 .

Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer.

H. Bartelink, V. Budach, R. Abdah-bortnyak, 2018 .

Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients

G. H. de Bock, S. Siesling, L. Strobbe, 2016, Breast Cancer Research and Treatment.

Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.

Mechthild Krause, M. S. Thomsen, T. B. Nyeng, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Postoperative radiation therapy for rectal cancer: An interim analysis of a prospective, randomized multicenter trial in the netherlands

P. Coucke, W. van Putten, A. Treurniet‐Donker, 1991 .

Prostatectomy vs radiation therapy for prostate cancer: The (still) unsolved dilemma.

A. Zietman, B. De Bari, P. Poortmans, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

2001 Acute toxicity of curative radiotherapy for intermediate risk localized prostate cancer in the EORTC trial 22991

L. Collette, M. Bolla, S. Sundar, 2009 .

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

S. Steinberg, E. Rutgers, E. Winer, 2018, The Lancet. Oncology.

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) in high grade malignant gliomas.

P. Lambin, J. Menten, H. Hamers, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

S. Linn, S. Siesling, L. Strobbe, 2016, The Lancet. Oncology.

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial

H. Bartelink, J. Horiot, J. Jager, 2004 .

[Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network].

R. Miralbell, G. Soete, G. Studer, 2004, Bulletin du cancer.